Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026

Madrigal Pharmaceuticals (NASDAQ:MDGL) will participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026 on June 10, 2026, at 11:20 A.M.

Rhea-AI Summary

Madrigal Pharmaceuticals (NASDAQ:MDGL) will participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026 on June 10, 2026, at 11:20 A.M. EDT.

The presentation will be available via live webcast through Madrigal’s Investor Relations Events and Presentations page, with a replay offered after the event.

Argus Jun 3 session

+7.79% close to close Open Argus

Details

News Market Reaction – MDGL

In the Jun 3 session, MDGL gained 7.79%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +7.8% in the session following this news. A strong positive reaction aligns with Mad...

Analysis

The stock moved +7.8% in the session following this news. A strong positive reaction aligns with Madrigal’s recent pattern of favorable responses to growth and data milestones, such as the 7.42% move after Q1 2026 results. This conference appearance follows multiple Rezdiffra data updates and ongoing commercialization momentum. Investors have also seen recent insider sales and equity awards, which could temper enthusiasm if valuation concerns emerge, but prior reactions to fundamentally supportive news have generally been constructive.

Key Figures

Conference date: June 10, 2026 Presentation time: 11:20 A.M. EDT Conference edition: 47th Annual

Conference date

June 10, 2026

Scheduled presentation at Goldman Sachs Health Care Conference

Presentation time

11:20 A.M. EDT

Timing of Madrigal’s conference session

Conference edition

47th Annual

Goldman Sachs Global Health Care Conference 2026

Historical Context

5 past events · Latest: May 27

5 events

1. May 27

   Clinical outcomes data

   24h Move

   +0.7%

   Phase 3 and real-world Rezdiffra data on cardiovascular and liver risk markers.

2. May 21

   Inducement equity grants

   24h Move

   +0.7%

   Equity inducement RSU awards to 15 non-executive employees under 2025 plan.

3. May 20

   Conference data preview

   24h Move

   -1.3%

   Planned EASL 2026 presentations on Rezdiffra cardiovascular and portal hypertension markers.

4. May 07

   Inducement equity awards

   24h Move

   -4.6%

   Stock options and RSUs granted to 47 new employees with vesting over four years.

5. May 06

   Earnings and pipeline

   24h Move

   +7.4%

   Q1 2026 results with strong Rezdiffra net sales, cash position, and pipeline expansion.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CONSHOHOCKEN, Pa., June 03, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 47^th Annual Global Goldman Sachs Health Care Conference 2026 on Wednesday, June 10, 2026, at 11:20 A.M. EDT.

The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events and Presentations page. A replay of the webcast will be available after the event.

About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra was the first medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit www.madrigalpharma.com and follow us on LinkedIn.

Investor Contact
Tina Ventura, IR@madrigalpharma.com

Media Contact
Christopher Frates, media@madrigalpharma.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Madrigal Pharmaceuticals (NASDAQ:MDGL) present at the 2026 Goldman Sachs Health Care Conference?

Madrigal Pharmaceuticals will present on June 10, 2026, at 11:20 A.M. EDT. According to the company, this session is part of the 47th Annual Global Goldman Sachs Health Care Conference 2026 and will be accessible via live webcast.

How can investors watch Madrigal Pharmaceuticals' Goldman Sachs Health Care Conference 2026 webcast?

Investors can watch Madrigal’s presentation via a live webcast linked on its Investor Relations Events and Presentations page. According to the company, online access will be available at the scheduled time of 11:20 A.M. EDT on June 10, 2026.

Will a replay of Madrigal Pharmaceuticals (MDGL) 2026 Goldman Sachs conference presentation be available?

Yes, a replay of Madrigal Pharmaceuticals’ conference webcast will be available after the event. According to the company, investors can access the replay through Madrigal’s Investor Relations Events and Presentations page following the June 10, 2026 presentation.

What is the significance of Madrigal Pharmaceuticals joining the 47th Annual Global Goldman Sachs Health Care Conference?

Madrigal’s participation offers investors another venue to hear management discuss the business. According to the company, the presentation will be webcast live, allowing broad access for shareholders and analysts interested in Madrigal’s latest updates and strategic commentary.

Where is information about Madrigal Pharmaceuticals' June 10, 2026 conference appearance posted for MDGL investors?

Information about Madrigal’s June 10, 2026 appearance is posted on its Investor Relations Events and Presentations page. According to the company, both the live webcast link and the subsequent replay will be accessible from that dedicated investor section.